The PALADIN study reported the intravitreal fluocinolone acetonide implant reduced the frequency of anti-VEGF injections in patients with diabetic macular edema out to 3 years. Medscape Medical News
Tag: Ophthalmology
Trio Who Invented Eye Test Wins Lasker Prize
‘America’s Nobel’ for medicine recognizes three researchers who developed optical coherence imaging, now widely used in ophthalmology. Medscape Medical News
Glaucoma: A Hidden Threat to Vision Health Rising Swiftly
"Late in the disease, people may notice they’re tripping over the curb, or walking into things they didn’t see. It really is only in very advanced disease that people notice there’s anything wrong." WebMD Health News
Battery Charged by Tears for Smart Contact Lenses
Researchers at Nanyang Technological University in Singapore have developed a tiny, flexible battery that is intended for use in smart contact lenses. The device is as thin as the human cornea and can be charged by a saline solution, which is particularly useful in the eye, as it is full of salty tears. When the […]
Adolescent Eye Health Worse With Vape and Cigarette Use
Using both cigarettes and vapes are apparently much worse for eye health than either product use alone, a new study found. Medscape Medical News
Chatbots as Accurate as Ophthalmologists in Giving Advice
The first study of the quality of ChatGPT answers for topics in eye care has found they’re on par with answers from ophthalmologists, who could not always distinguish human from AI responses. Medscape Medical News
Avoid 2 Eye Drop Products, FDA Advises
The FDA is urging the public to avoid buying or using two different kinds of eye drops because of possible bacterial or fungal contamination. WebMD Health News
Study Questions if Blue Light Blocking Glasses Really Work
Despite claims by their makers, blue light glasses probably don’t reduce eyestrain for people who spend a lot of time looking at computer screens or phones. WebMD Health News
Primary Care Vision Testing Rates in Children Low
Vision testing rates by primary care physicians in children were low and differed by insurance status, an anlysis of pooled data found. MDedge News
Light-Activated Hydrogel Thickens, Reshapes Thinning Cornea
Researchers at the University of Ottawa have developed a light-activated hydrogel treatment for corneal disease. Many of the people who suffer from corneal disease, which can include corneal thinning, are not suitable for a corneal transplant, and obtaining transplants is a challenge for those who are. This technology is intended to assist with thickening and […]
Long-Term Outcomes of Pegcetacoplan for GA Show Promise
Results of the 30-month data cut of the 3-year GALE open-label extension trial of pegcetacoplan for geographic atrophy showed that the drug produced clinically meaningful reductions in lesion growth. Medscape Medical News
Complications From Geographic Atrophy Drug Fuel Questions
An extension study found no cases of occlusive retinal vasculitis after 23,000 injections of pegcetacoplan, but a panel received more reports of the complication and dealt with conflicts of interest. Medscape Medical News
Do GLP-1 Agonists Worsen Diabetic Retinopathy?
Patients taking glucagon-like peptide-1 agonists were more likely to progress from nonproliferative diabetic retinopathy to proliferative disease or diabetic macular edema than those who took sodium-glucose cotransporter-2 inhibitors. Medscape Medic…
Biosimilars Comparable to Aflibercept in Macular Disease
Phase 3 registration trials found the comparability of two biosimilars to reference aflibercept in terms of efficacy, safety, pharmacokinetics, and immunogenicity. Medscape Medical News
Higher Aflibercept Dose Safe as 2 mg
The PULSAR trial of a higher dosage formulation extended the treatment interval to 12 or 16 weeks. Medscape Medical News
Study Shows Vision, Anatomy Stable With Port System for AMD
Recalled in 2022, a port delivery system for ranibizumab to treat wet AMD demonstrated that vision and retinal anatomy remained stable in patients who had the device for 5 years. Medscape Medical News
Study: AMD Gene Therapy Demonstrates Vision Stabilization
An early gene therapy trial reported maintenance of vision, reduced retinal inflammation, and detectable therapeutic protein levels 9 months after treatment for age-related macular degeneration. Medscape Medical News
From Chronic Care to Zebras: Clinical Pearls in Uveitis
Nisha Acharya, MD, advocated long-term treatment for chronic or recurrent uveitis, exploring less-common causes, and multimodal imaging. Medscape Medical News
ASRS 2023
Read clinically focused news coverage of key developments from ASRS 2023 Medscape Ophthalmology
Retina Group Warns on Complications From New GA Drug
The American Society of Retina Specialists has reported six cases of vasculitis not seen in clinical trials. Medscape Medical News